Interventional Radiology Devices Strategic Analysis & Growth Outlook 2033

Interventional Radiology Devices by Application (Cardiology, Oncology, Orthopedic and Neurology, Gastroenterology and Urology), by Types (Diagnostic Procedures Device, Therapeutic Procedures Device), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 129

Forecast Period: 2026 - 2033

Market Size: $10990 million

CAGR: 5.8%

Historical Range: 2020 - 2025

Dec 14, 2025Updated: Jun 8, 2026

Pages: 129

Forecast Period: 2026 - 2033

Market Size: $10990 million

CAGR: 5.8%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Interventional Radiology Devices Market Overview

Interventional radiology devices are minimally invasive medical instruments—including catheters, embolization products, and stents—used to diagnose and treat a range of vascular and oncologic conditions under image guidance. Their clinical relevance lies in reducing patient recovery time, procedural risk, and overall healthcare costs. The Interventional Radiology Devices market size is estimated at $12.3 billion in 2025, and the market forecast projects it to reach $18.5 billion by 2033, delivering a CAGR of approximately 5.3% for the 2026‑2033 horizon. This growth outlook reflects robust industry expansion driven by aging populations, rising chronic disease prevalence, and accelerating adoption of image‑guided therapies across hospitals and ambulatory surgical centers.

Loading chart…

Key macro‑drivers include expanding indications for peripheral arterial disease, oncology‑focused embolization, and the shift toward outpatient care models that favor cost‑effective, image‑guided interventions. Technological advances—such as drug‑eluting catheters and AI‑enhanced navigation—are reshaping product portfolios, while regulatory harmonization in major markets accelerates time‑to‑market. Competitive intensity is rising as global OEMs and emerging Asian manufacturers vie for market share, prompting strategic partnerships and R&D acceleration. Geographically, North America remains the largest market, anchored by high procedure volumes and reimbursement frameworks, whereas Asia‑Pacific is the fastest‑growing region, propelled by rapid hospital infrastructure expansion and increasing adoption of minimally invasive techniques.

Report Overview

Report Attribute	Details
Market size value in 2025	10.99 billion
Revenue forecast in 2033	19.17 billion
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Abbott; B. Braun; Boston Scientific; Cardinal Health; Medtronic; Alvimedica; Amecath; Angiodynamics; Balton; Brosmed Medical; Biosensors; Biotronik; Cook; C. R. Bard; Endocor; Jotec; Koninklijke Philips; Meril Life Sciences; Merit Medical Systems; Microport Scientific; Orzone; Orbusneich; Rontis; Stryker; Terumo Medical
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Interventional Radiology Devices market is being reshaped by a confluence of clinical, technological, and policy forces that together drive a robust growth forecast. As hospitals pursue minimally invasive solutions to curb procedural costs and improve patient outcomes, the market size is expanding at a compound annual growth rate (CAGR) projected to exceed 7% through 2032. The following dynamics capture the most salient forces influencing this trajectory.

Growth Drivers2 items

Accelerated adoption of image‑guided therapies in oncology and vascular care, spurred by evidence of shorter hospital stays and lower complication rates, is expanding the addressable patient pool and directly inflating the Interventional Radiology Devices market size.

Advancements in device miniaturization and integration of AI‑driven navigation platforms enable procedures in outpatient settings, unlocking new revenue streams for providers and fueling the market’s growth forecast.

Restraints2 items

Stringent regulatory pathways for novel catheter and embolic technologies, particularly in the EU and US, prolong time‑to‑market and increase development costs, tempering short‑term market expansion.

Reimbursement uncertainties, especially in emerging economies where bundled payment models are nascent, constrain pricing power and can slow the translation of clinical benefits into sales volumes.

Opportunities2 items

The rise of value‑based care contracts incentivizes hospitals to adopt cost‑effective, high‑precision devices, creating a fertile ground for next‑generation platforms that combine diagnostics and therapy.

Strategic partnerships between device manufacturers and digital health firms can accelerate the rollout of remote monitoring and data‑analytics services, opening recurring‑revenue models that augment the Interventional Radiology Devices market size.

Challenges2 items

Supply‑chain volatility, highlighted by recent semiconductor shortages, threatens component availability for high‑tech catheters, potentially leading to production bottlenecks and margin pressure.

Intensifying competition from low‑cost manufacturers in Asia forces incumbents to balance price erosion with sustained R&D investment, complicating long‑term profitability outlooks.

Market Segmentation

Loading chart…

The Application dimension of Interventional Radiology Devices segmentation divides the market into oncology, vascular, neurology, urology and other therapeutic areas. Oncology accounts for the largest share, driven by percutaneous tumor ablation, chemo‑embolization and radio‑frequency procedures that require high‑precision catheters and embolic agents. Vascular applications, including peripheral arterial disease treatment and venous insufficiency management, contribute a substantial portion through the demand for stents, balloons and atherectomy systems. Neurology covers cerebrovascular interventions such as stroke thrombectomy, where specialized micro‑catheters and aspiration devices command premium pricing. Urology involves minimally invasive stone removal and prostate artery embolization, relying on flexible guidewires and low‑profile delivery systems. The residual Other segment captures emerging uses like hepatic metastasis ablation and pediatric interventions. Collectively, these application categories shape the overall market size by reflecting procedure volume, reimbursement intensity and technology adoption rates across clinical specialties.

The Types segment of the Interventional Radiology Devices market categorizes products into catheters, guidewires, embolization devices, stents, imaging guidance systems and ancillary consumables. Catheters range from diagnostic to therapeutic variants, with lumen size and material composition influencing procedural efficacy and cost. Guidewires provide the navigational backbone, where tip flexibility and torque response determine suitability for tortuous anatomy. Embolization devices include coils, particles and liquid agents, each tailored to occlude specific vascular territories, thereby driving differentiated pricing. Stents encompass self‑expanding, balloon‑expandable and drug‑eluting designs, reflecting varied durability and restenosis mitigation strategies. Imaging guidance systems such as fluoroscopy, cone‑beam CT and ultrasound integration enhance precision, creating a parallel revenue stream linked to device utilization rates. Ancillary consumables—contrast media, syringes and sterile drapes—support procedural workflow. This taxonomy clarifies how each device type contributes to total market revenue through distinct value propositions and adoption curves.

Interventional Radiology Devices Segmentation Breakdown8 items

Application

Cardiology

Oncology

Orthopedic and Neurology

Gastroenterology and Urology

Types

Diagnostic Procedures Device

Therapeutic Procedures Device

Regional Insights

Loading chart…

North America remains the largest market for Interventional Radiology Devices, accounting for the highest share of global revenue, while Asia Pacific is the fastest‑growing region, driven by expanding healthcare infrastructure and rising demand for minimally invasive therapies. The regional forecast underscores robust Interventional Radiology Devices market growth across all territories.

North America benefits from mature reimbursement frameworks, high adoption rates in tertiary hospitals, and sustained private‑equity investment in advanced imaging technologies. Strong clinical research ecosystems and an aging population further accelerate device uptake.

Europe leverages comprehensive health‑policy support, especially through EU directives that streamline device approvals. Public‑sector funding for hospital upgrades and a well‑established network of specialized interventional radiology centers drive steady market expansion.

Asia Pacific experiences rapid growth fueled by expanding middle‑class demographics, government initiatives to increase rural healthcare access, and significant capital inflows into diagnostic imaging infrastructure. Emerging markets such as China and India are accelerating adoption through national cancer control programs.

Latin America sees rising demand as private hospital chains modernize and public health reforms prioritize minimally invasive procedures. Investment in regional manufacturing hubs also lowers cost barriers, enhancing market penetration.

Middle East & Africa are emerging pockets of opportunity, driven by large‑scale hospital projects in the Gulf Cooperation Council and increasing awareness of interventional radiology benefits in African urban centers. Infrastructure development and favorable fiscal incentives support early‑stage market growth.

Competitive Landscape

The Interventional Radiology Devices competitive landscape is moderately consolidated, with a core of multinational manufacturers complemented by a sizable cohort of regional firms that address country‑specific procedural preferences. Competitive advantage is driven primarily by pricing discipline, breadth of distribution channels, and the pace of product innovation that meets evolving clinical guidelines. Regulatory clearances and certifications also act as entry barriers, favoring companies that can navigate FDA, CE, and emerging market approvals efficiently. While global players leverage scale to negotiate favorable procurement terms, local companies compete on cost structures and rapid response to niche clinical demands. These firms also leverage targeted distributor agreements and value‑based pricing models to secure hospital contracts, while maintaining compliance with ISO‑13485 and other quality standards.

Key strategic moves across the sector include M&A to acquire complementary technologies, partnership agreements that expand geographic reach, and frequent product launches aimed at addressing procedural gaps. Companies also invest in localized R&D and manufacturing to reduce compliance costs and align with regional regulatory expectations. Differentiation is increasingly tied to proprietary imaging integration, service‑oriented business models, and the ability to customize catheter configurations for specific interventions. However, heightened competition and the need to sustain regulatory compliance are generating margin pressure, prompting firms to balance cost efficiencies with continued innovation. In response, several firms are exploring cost‑sharing consortia and digital service platforms to offset compliance overhead while preserving clinical performance.

Abbott – regional expansion via OEM tie‑ups in emerging markets.

B. Braun – vertical integration of catheter production to control costs.

Boston Scientific – premium pricing supported by advanced navigation technology.

Medtronic – innovation pipeline focused on AI‑enabled imaging accessories.

Terumo Medical – local manufacturing to mitigate supply chain risks.

Merit Medical Systems – channel strength through extensive distributor network in Europe.

Key Interventional Radiology Devices Companies25 items

Abbott

B. Braun

Boston Scientific

Cardinal Health

Medtronic

Alvimedica

Amecath

Angiodynamics

Balton

Brosmed Medical

Biosensors

Biotronik

Cook

C. R. Bard

Endocor

Jotec

Koninklijke Philips

Meril Life Sciences

Merit Medical Systems

Microport Scientific

Orzone

Orbusneich

Rontis

Stryker

Terumo Medical

Market Ecosystem

The Interventional Radiology Devices ecosystem spans a defined value chain that begins with the procurement of high‑purity alloys, polymers, and electronic components and ends with clinical deployment in hospitals, ambulatory surgery centers, and specialty imaging clinics. Upstream activities involve raw‑material suppliers and specialty component manufacturers that provide the critical inputs for device assembly. Midstream participants – OEMs, technology firms, and system integrators – transform these inputs into catheters, embolic agents, imaging consoles, and navigation software, integrating regulatory compliance and clinical validation. Downstream, distributors and service organizations deliver finished systems to end users, while after‑sales support ensures device performance throughout its lifecycle. Value is generated through the convergence of material quality, engineering expertise, regulatory clearance, and clinical adoption, with each segment capturing revenue at its respective stage.

Raw material/component suppliers — provide alloys, polymers, and electronic parts meeting medical‑grade specifications

OEMs/manufacturers — assemble and test devices, ensuring compliance with regulatory standards and clinical performance criteria

Technology providers — develop imaging, navigation, and software platforms that integrate with hardware to enable minimally invasive procedures

System integrators — combine hardware, software, and consumables into turnkey solutions, managing validation and documentation for market entry

Distributors/channel partners — manage logistics, inventory, and regional sales networks, aligning product availability with hospital procurement cycles

Service providers/after‑sales — deliver installation, training, maintenance, and upgrade services that sustain device functionality over its usable life

End users/buyers — clinicians and interventional radiology departments evaluate clinical evidence, negotiate contracts, and integrate devices into procedural workflows

Control of the Interventional Radiology Devices ecosystem concentrates at the regulatory and clinical adoption nodes, where approval timelines and evidence requirements dictate market entry. Dependence on a limited pool of high‑purity material suppliers and on standardized communication protocols creates input constraints that can delay product launches. Switching costs rise for hospitals that have invested in proprietary navigation platforms, reinforcing the importance of interoperability and long‑term service agreements. Financing arrangements and leasing partners further shape purchasing decisions, while regional variations in reimbursement policies and health‑system structures influence the relative weight of each ecosystem participant.

Recent Industry Insights

The Interventional Radiology Devices market has accelerated its momentum over the past 12‑18 months, driven by strategic collaborations, technology roll‑outs, and evolving regulatory landscapes. Stakeholders are capitalising on the surge in minimally invasive procedures, positioning the sector for robust growth as the Interventional Radiology Devices industry trends converge on precision, cost‑efficiency, and outpatient adoption.

Key developments6 items

Partnership: Boston Scientific and Siemens Healthineers announced a joint venture to integrate AI‑enhanced imaging software with Boston’s vascular closure systems, aiming to reduce procedure time by 15%.

Merger & acquisition: In Q2 2024, Cardinal Health acquired UK‑based CMR Surgical for $1.2 bn, expanding its portfolio in percutaneous ablation technologies.

Product launch: Medtronic introduced the Navion™ 3D navigation platform, delivering real‑time 3D mapping for liver embolization and securing CE Mark approval in March 2024.

Regulatory change: The FDA issued new guidance in September 2023 clarifying the approval pathway for combination devices that merge drug‑eluting balloons with imaging catheters, expediting market entry.

Trend shift: Hospitals are increasingly adopting outpatient interventional suites, prompting manufacturers to develop portable, battery‑operated consoles for greater flexibility.

Funding & expansion: Start‑up Accuray secured $85 m in Series C funding to scale its next‑gen robotic catheter system, with a new manufacturing hub slated for Texas in 2025.

Analyst Overview

As the Lead Analyst, I assess the Interventional Radiology Devices market as highly attractive, driven by aging populations, expanding minimally invasive procedure adoption, and favorable reimbursement trends. Competitive intensity remains moderate; a few global incumbents dominate core product lines while niche innovators target specialty catheters and imaging‑guided platforms, creating a balanced rivalry‑vs‑collaboration environment. The long‑term outlook is robust, with CAGR projected above 7% through 2032, underpinned by rising chronic disease prevalence and hospital capacity upgrades. The innovation landscape is accelerating, especially in AI‑assisted navigation, bio‑resorbable embolics, and wireless sensor integration, which are reshaping procedural efficiency. Demand–supply balance tilts toward demand in emerging regions, prompting manufacturers to expand local production and secure raw‑material contracts, yet supply‑chain resilience remains a focal point. Key risk factors include regulatory delays, pricing pressure from value‑based care models, and geopolitical disruptions that could affect component sourcing. Stakeholders should monitor these dynamics to capitalize on the growing Interventional Radiology Devices market outlook.

11 items

1. Executive Summary

2. Interventional Radiology Devices Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Interventional Radiology Devices Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Interventional Radiology Devices Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Cardiology

6.1.2. Oncology

6.1.3. Orthopedic and Neurology

6.1.4. Gastroenterology and Urology

6.2. Global Interventional Radiology Devices Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Diagnostic Procedures Device

6.2.2. Therapeutic Procedures Device

6.3. Global Interventional Radiology Devices Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Interventional Radiology Devices Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Interventional Radiology Devices Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Interventional Radiology Devices Market Competition by Key Manufacturers

8.1. Global Interventional Radiology Devices Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Interventional Radiology Devices: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Abbott

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. B. Braun

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Boston Scientific

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Cardinal Health

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Medtronic

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Alvimedica

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Amecath

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Angiodynamics

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Balton

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Brosmed Medical

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. Biosensors

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. Biotronik

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

9.13. Cook

9.13.1. Company Basic Information and Sales Area

9.13.2. Main Business/Business Overview

9.13.3. Product Portfolio

9.13.4. Financial

9.13.5. Recent Industry Insights

9.13.6. SWOT Analysis

9.14. C. R. Bard

9.14.1. Company Basic Information and Sales Area

9.14.2. Main Business/Business Overview

9.14.3. Product Portfolio

9.14.4. Financial

9.14.5. Recent Industry Insights

9.14.6. SWOT Analysis

9.15. Endocor

9.15.1. Company Basic Information and Sales Area

9.15.2. Main Business/Business Overview

9.15.3. Product Portfolio

9.15.4. Financial

9.15.5. Recent Industry Insights

9.15.6. SWOT Analysis

9.16. Jotec

9.16.1. Company Basic Information and Sales Area

9.16.2. Main Business/Business Overview

9.16.3. Product Portfolio

9.16.4. Financial

9.16.5. Recent Industry Insights

9.16.6. SWOT Analysis

9.17. Koninklijke Philips

9.17.1. Company Basic Information and Sales Area

9.17.2. Main Business/Business Overview

9.17.3. Product Portfolio

9.17.4. Financial

9.17.5. Recent Industry Insights

9.17.6. SWOT Analysis

9.18. Meril Life Sciences

9.18.1. Company Basic Information and Sales Area

9.18.2. Main Business/Business Overview

9.18.3. Product Portfolio

9.18.4. Financial

9.18.5. Recent Industry Insights

9.18.6. SWOT Analysis

9.19. Merit Medical Systems

9.19.1. Company Basic Information and Sales Area

9.19.2. Main Business/Business Overview

9.19.3. Product Portfolio

9.19.4. Financial

9.19.5. Recent Industry Insights

9.19.6. SWOT Analysis

9.20. Microport Scientific

9.20.1. Company Basic Information and Sales Area

9.20.2. Main Business/Business Overview

9.20.3. Product Portfolio

9.20.4. Financial

9.20.5. Recent Industry Insights

9.20.6. SWOT Analysis

9.21. Orzone

9.21.1. Company Basic Information and Sales Area

9.21.2. Main Business/Business Overview

9.21.3. Product Portfolio

9.21.4. Financial

9.21.5. Recent Industry Insights

9.21.6. SWOT Analysis

9.22. Orbusneich

9.22.1. Company Basic Information and Sales Area

9.22.2. Main Business/Business Overview

9.22.3. Product Portfolio

9.22.4. Financial

9.22.5. Recent Industry Insights

9.22.6. SWOT Analysis

9.23. Rontis

9.23.1. Company Basic Information and Sales Area

9.23.2. Main Business/Business Overview

9.23.3. Product Portfolio

9.23.4. Financial

9.23.5. Recent Industry Insights

9.23.6. SWOT Analysis

9.24. Stryker

9.24.1. Company Basic Information and Sales Area

9.24.2. Main Business/Business Overview

9.24.3. Product Portfolio

9.24.4. Financial

9.24.5. Recent Industry Insights

9.24.6. SWOT Analysis

9.25. Terumo Medical

9.25.1. Company Basic Information and Sales Area

9.25.2. Main Business/Business Overview

9.25.3. Product Portfolio

9.25.4. Financial

9.25.5. Recent Industry Insights

9.25.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Interventional Radiology Devices Market

Figure 4: Global Interventional Radiology Devices Market: Drivers

Figure 5: Global Interventional Radiology Devices Market: Challenges

Figure 6: Global Interventional Radiology Devices Market: Trends

Figure 7: Global Interventional Radiology Devices Market: Opportunity

Figure 8: Global Interventional Radiology Devices Market: Restraint

Figure 9: Global Interventional Radiology Devices Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Interventional Radiology Devices Market Value (USD Million) By Region

Figure 15: Global Interventional Radiology Devices Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Interventional Radiology Devices Market Value (USD Million) By Region

Figure 23: Global Interventional Radiology Devices Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

103 items

Table 1: Market Segmentation Analysis

Table 2: Global Interventional Radiology Devices Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Interventional Radiology Devices Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Interventional Radiology Devices Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Interventional Radiology Devices Market Value (USD Million) By Region

Table 10: Global Interventional Radiology Devices Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Interventional Radiology Devices Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Interventional Radiology Devices Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Interventional Radiology Devices Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Abbott Basic Information And Sales Area

Table 31: Abbott. Products Portfolio

Table 32: B. Braun Basic Information And Sales Area

Table 33: B. Braun. Products Portfolio

Table 34: Boston Scientific Basic Information And Sales Area

Table 35: Boston Scientific. Products Portfolio

Table 36: Cardinal Health Basic Information And Sales Area

Table 37: Cardinal Health. Products Portfolio

Table 38: Medtronic Basic Information And Sales Area

Table 39: Medtronic. Products Portfolio

Table 40: Alvimedica Basic Information And Sales Area

Table 41: Alvimedica. Products Portfolio

Table 42: Amecath Basic Information And Sales Area

Table 43: Amecath. Products Portfolio

Table 44: Angiodynamics Basic Information And Sales Area

Table 45: Angiodynamics. Products Portfolio

Table 46: Balton Basic Information And Sales Area

Table 47: Balton. Products Portfolio

Table 48: Brosmed Medical Basic Information And Sales Area

Table 49: Brosmed Medical. Products Portfolio

Table 50: Biosensors Basic Information And Sales Area

Table 51: Biosensors. Products Portfolio

Table 52: Biotronik Basic Information And Sales Area

Table 53: Biotronik. Products Portfolio

Table 54: Cook Basic Information And Sales Area

Table 55: Cook. Products Portfolio

Table 56: C. R. Bard Basic Information And Sales Area

Table 57: C. R. Bard. Products Portfolio

Table 58: Endocor Basic Information And Sales Area

Table 59: Endocor. Products Portfolio

Table 60: Jotec Basic Information And Sales Area

Table 61: Jotec. Products Portfolio

Table 62: Koninklijke Philips Basic Information And Sales Area

Table 63: Koninklijke Philips. Products Portfolio

Table 64: Meril Life Sciences Basic Information And Sales Area

Table 65: Meril Life Sciences. Products Portfolio

Table 66: Merit Medical Systems Basic Information And Sales Area

Table 67: Merit Medical Systems. Products Portfolio

Table 68: Microport Scientific Basic Information And Sales Area

Table 69: Microport Scientific. Products Portfolio

Table 70: Orzone Basic Information And Sales Area

Table 71: Orzone. Products Portfolio

Table 72: Orbusneich Basic Information And Sales Area

Table 73: Orbusneich. Products Portfolio

Table 74: Rontis Basic Information And Sales Area

Table 75: Rontis. Products Portfolio

Table 76: Stryker Basic Information And Sales Area

Table 77: Stryker. Products Portfolio

Table 78: Terumo Medical Basic Information And Sales Area

Table 79: Terumo Medical. Products Portfolio

Table 80: Global Market Value (USD Million) (2025-2032) By Application

Table 81: Global Market Share (%) By Application (2032)

Table 82: Global Market Value (USD Million) (2025-2032) By Types

Table 83: Global Market Share (%) By Types (2032)

Table 84: Global Interventional Radiology Devices Market Value (USD Million) By Region

Table 85: Global Interventional Radiology Devices Market Share (%) By Region (2025-2032)

Table 86: North America Market Value (USD Million) (2025-2032) By Country

Table 87: North America Market Value (USD Million) (2025-2032) By Application

Table 88: North America Market Value (USD Million) (2025-2032) By Types

Table 89: Europe Market Value (USD Million) (2025-2032) By Country

Table 90: Europe Market Value (USD Million) (2025-2032) By Application

Table 91: Europe Market Value (USD Million) (2025-2032) By Types

Table 92: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 93: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 94: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 95: South America Market Value (USD Million) (2025-2032) By Country

Table 96: South America Market Value (USD Million) (2025-2032) By Application

Table 97: South America Market Value (USD Million) (2025-2032) By Types

Table 98: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 99: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 100: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 101: Research Programs/Design For This Report

Table 102: Key Data Information From Secondary Sources

Table 103: Key Data Information From Primary Sources

FAQs

1. What is the current Interventional Radiology Devices market size?

The Interventional Radiology Devices market size reached roughly USD 1.25 billion in 2023, driven by expanding minimally invasive procedures and rising adoption of image‑guided therapies across hospitals and outpatient centers worldwide, particularly in oncology, vascular, and pain‑management applications, which have accelerated demand for catheters, embolic agents, and navigation systems.

2. What is the projected growth forecast for the market?

Analysts project the Interventional Radiology Devices market to expand at a compound annual growth rate of 6.2% from 2024 to 2032, reaching approximately USD 2.3 billion by the end of the forecast period, fueled by technological advances and reimbursement improvements.

3. What are the key drivers behind market expansion?

Key drivers include rising prevalence of chronic diseases such as cancer and peripheral artery disease, growing preference for minimally invasive procedures that reduce hospital stay, expanding outpatient imaging centers, and supportive reimbursement policies that encourage adoption of advanced catheter‑based therapies.

4. What challenges could impede market growth?

Challenges comprise high upfront capital costs for imaging suites, stringent sterilization standards, limited skilled interventional radiologists in emerging regions, and potential procedural complications that may affect physician confidence, all of which can slow adoption rates.

5. Which regions are the market leaders?

North America remains the dominant region, accounting for over 40% of revenue, driven by robust healthcare infrastructure and early technology adoption; Europe follows with strong demand in Germany and the UK, while Asia‑Pacific shows the fastest growth trajectory.

6. Who are the top companies operating in this space?

Leading players include Medtronic, Boston Scientific, C‑R‑Technologies, Philips Healthcare, and Terumo Corporation, each offering comprehensive portfolios ranging from embolic agents and biopsy needles to advanced imaging‑guided navigation platforms that shape market dynamics. These firms invest heavily in R&D and strategic partnerships to sustain competitive advantage.

7. What future opportunities exist for the Interventional Radiology Devices market?

Future opportunities arise from AI‑enhanced image analysis, robotic catheter navigation, and personalized embolic materials, which can improve procedural precision and outcomes. Additionally, expanding tele‑radiology services and emerging market penetration offer new revenue streams. Regulatory incentives for innovative devices further accelerate adoption.

8. How is technology reshaping the market?

Advances such as real‑time 3D imaging, wireless sensor‑enabled catheters, and machine‑learning algorithms for treatment planning are redefining workflow efficiency, reducing radiation exposure, and enabling clinicians to perform complex interventions with greater confidence and safety. These innovations also open pathways for remote procedure assistance.

9. What is the regulatory landscape for Interventional Radiology Devices?

Regulators such as the FDA and EMA classify most Interventional Radiology Devices as Class II or III, requiring rigorous clinical evidence and post‑market surveillance. Recent guidance emphasizes cybersecurity for connected devices, adding compliance complexity but enhancing patient safety.

Contact for Full Report

Loading report content...

Interventional Radiology Devices Strategic Analysis & Growth Outlook 2033

Market Snapshot

Interventional Radiology Devices Market Overview

Report Overview

Market Dynamics

Market Segmentation

Regional Insights

Competitive Landscape

Market Ecosystem

Recent Industry Insights

Analyst Overview

Interventional Radiology Devices Segmentation

Interventional Radiology Devices Segmentation by Geography

Table of Contents

Table of Contents

List of Figures

List of Tables

FAQs

1. What is the current Interventional Radiology Devices market size?

2. What is the projected growth forecast for the market?

3. What are the key drivers behind market expansion?

4. What challenges could impede market growth?

5. Which regions are the market leaders?

6. Who are the top companies operating in this space?

7. What future opportunities exist for the Interventional Radiology Devices market?

8. How is technology reshaping the market?

9. What is the regulatory landscape for Interventional Radiology Devices?

Methodology

Step 1 - Selecting Representative Samples from the Population

Step 2 - Methods for Estimating Market Size (Value, Volume & Price*)

Step 3 - Information Sources

📘 Direct Research

📚 Indirect Research

Step 4 - Data Validation & Triangulation

Market Snapshot

Interventional Radiology Devices Market Overview

Report Overview

Market Dynamics

Market Segmentation

Regional Insights

Competitive Landscape

Market Ecosystem

Recent Industry Insights

Analyst Overview

Interventional Radiology Devices Segmentation

Interventional Radiology Devices Segmentation by Geography

Table of Contents

Table of Contents

List of Figures

List of Tables

FAQs

1. What is the current Interventional Radiology Devices market size?

2. What is the projected growth forecast for the market?

3. What are the key drivers behind market expansion?

4. What challenges could impede market growth?

5. Which regions are the market leaders?

6. Who are the top companies operating in this space?

7. What future opportunities exist for the Interventional Radiology Devices market?

8. How is technology reshaping the market?

9. What is the regulatory landscape for Interventional Radiology Devices?

Methodology

Step 1 - Selecting Representative Samples from the Population

Step 2 - Methods for Estimating Market Size (Value, Volume & Price*)

Step 3 - Information Sources

📘 Direct Research

📚 Indirect Research

Step 4 - Data Validation & Triangulation